Trial Details
COMPLETEDBasic Information
| Clinical ID | c4422 |
|---|---|
| Identifier | NCT00552565 |
| Trial Title | Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome With Diarrhea |
| Interventions | DRUG: Rezular 15mg|DRUG: Placebo|DRUG: Rezular|DRUG: Rezular |
Participant Information
| Sponsor | AGI Therapeutics, Inc. |
|---|---|
| City | Wilmington |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2007-09 |
|---|---|
| Primary Completion Date | 2009-06 |
| Completion Date | 2009-06 |